iTRAQ-Based Proteomic Analysis of Ginsenoside F2 on Human Gastric Carcinoma Cells SGC7901

Ginsenoside F2 (F2), a protopanaxdiol type of saponin, was reported to inhibit human gastric cancer cells SGC7901. To better understand the molecular mechanisms of F2, an iTRAQ-based proteomics approach was applied to define protein expression profiles in SGC7901 cells in response to lower dose (20 ...

Full description

Bibliographic Details
Main Authors: Qian Mao, Pin-Hu Zhang, Jie Yang, Jin-Di Xu, Ming Kong, Hong Shen, He Zhu, Min Bai, Li Zhou, Guang-Fu Li, Qiang Wang, Song-Lin Li
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2016/2635483

Similar Items